Most material SEC filings — July 28, 2026

Blink Charging Co. filed an 8-K on July 28, 2026 disclosing Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The filing provides no specific details on which exchange listing rule was violated, the nature of the deficiency, remediation timeline, or corrective actions. The actual substance of the delisting notice is not disclosed in this 8-K excerpt.

Two Harbors Investment Corp. (TWO) announced its second quarter 2026 results and confirmed its pending merger with CrossCountry Mortgage, LLC (CCM). TWO common shareholders will receive $12.00 per share; preferred shareholders (Series A, B, C) will be redeemed at $25.00 per share plus accrued dividends. Stockholder approval was obtained July 2, 2026; closing is expected August 3, 2026, subject to remaining conditions. Q2 generated $47.9M comprehensive income ($0.45/share), book value of $10.68/share, and a $0.34 quarterly dividend (4.3% economic return on book value).

IonQ (NYSE: IONQ) received final regulatory approval on July 28, 2026 to complete its acquisition of SkyWater Technology (NASDAQ: SKYT), announced in January 2026. The transaction is expected to close on July 31, 2026. SkyWater will operate as a wholly owned subsidiary of IonQ under the SkyWater name, continuing to serve customers as a U.S.-based semiconductor foundry while providing IonQ's quantum computing division with a domestically secured supply chain.

Caesars reported Q2 2026 net revenues of $3.0B (vs. $2.9B prior year, +3.0%), but Adjusted EBITDA declined to $920M from $955M YoY. Net loss improved to $62M from $82M. The company disclosed a pending definitive acquisition agreement by Fertitta Entertainment announced May 28, 2026, which will make Caesars private and delist from NASDAQ. Total debt stands at $11.8B with $965M cash; net debt of $10.8B. Las Vegas segment underperformed (-3.5% revenue, -12.6% EBITDA), while Regional grew 9.4% revenue and 11.2% EBITDA.

10% owner L1 Capital Pty Ltd (AVR) bought 6.3M shares (~$35.3M) on the open market (54% of holdings). Open-market insider purchase — historically a bullish signal.

BayFirst Financial Corp. (market cap ~$49.3M) announced on July 28, 2026 that it is rescheduling its Q2 2026 earnings release to August 13, 2026 and conference call to August 14, 2026. The company disclosed that consolidated financial statements for the years ended December 31, 2024 and 2025, and the quarter ended March 31, 2026, must be restated and should no longer be relied upon. The restatement was disclosed in a July 14, 2026 Form 8-K that also reported implementation of an asset resolution plan; amended 2025 Form 10-K and Q1 2026 Form 10-Q filings are expected by August 12, 2026.

On July 27, 2026, Polar Power Inc. entered into a Common Stock Purchase Agreement with Roth Principal Investments, LLC providing a committed equity facility of up to $25 million in gross proceeds over 36 months. The company may sell shares at 97% of volume-weighted average price (3% discount) for regular-hours trades and 95% (5% discount) for extended-hours trades. Up to 18.3 million shares (476% of current outstanding shares) are registered for resale; however, actual drawdown is severely limited to ~$1.3 million until stockholder approval is obtained under Nasdaq Rule 5635(d), due to the 19.99% Exchange Cap. The company will pay Roth a $500,000 commitment fee (2% of facility), $75,000 in legal reimbursements, and $50,000 to a qualified independent underwriter.

Entera Bio Ltd. entered into a securities purchase agreement dated July 26, 2026, to issue ordinary shares and pre-funded warrants at $2.04 per share to multiple purchasers, with a minimum aggregate subscription of $210 million required for closing. BVF Partners L.P. and its affiliates are designated purchasers with board designation and voting rights. The company reserved shares, granted registration rights, and agreed to board seat appointments conditional on BVF maintaining 75% or more ownership of purchased shares.

Element Solutions Inc entered into an Agreement and Plan of Merger with Solstice Advanced Materials Inc, effective July 6, 2026. The filing discloses change-of-control provisions: EVP John E. Capps will receive $3.0M total severance ($600K incentive + $2.4M termination) if he resigns within 30 days post-closing, treating it as a 'Good Reason' termination. The merger agreement itself is not fully detailed in these exhibits; only executive compensation impact is shown.

Professional Diversity Network, Inc. filed an amended Form S-1 registering a best-efforts offering of up to ~$10M in units and pre-funded units, with Maxim Group LLC as sole placement agent. Maxim receives 6% cash fee on gross proceeds, up to $75K expense reimbursement if closing occurs (capped at $50K if no closing), plus 6% tail financing fee for 6 months post-closing and 90-day ROFR on future offerings. Warrants (common and pre-funded) exercisable for common stock at prices to be determined are included; pre-funded warrants have nominal $0.0001 exercise price. Company represents ~$5.3M market value; offering size is ~188% of market cap.

U.S. District Court for Southern District of New York ordered Papaya Gaming to pay Skillz Platform Inc. (Firy subsidiary) $719 million in disgorgement of unjust profits from false advertising (Lanham Act violation), plus ~$10 million in attorney's fees. This exceeds the April 2026 jury award of $420 million by ~$300 million. Court rejected all post-trial challenges; Papaya used bots representing 70% of advertised prize money ($4.7B of $6.7B) between 2021–2024.

Director Aghazadeh Behzad (SCTX) bought 2.4M shares (~$36.3M) on the open market (44% of holdings). Open-market insider purchase — historically a bullish signal.

ProMIS reported blinded 6-month interim safety and biomarker data from PRECISE-AD, a Phase 1b trial of PMN310 in 136 mild cognitive impairment/mild AD patients (61% APOE4 carriers, 11% homozygotes). Key findings: zero ARIA-E cases across all genotypes, 4.4% total ARIA (all mild asymptomatic ARIA-H), zero treatment-related serious adverse events, zero drug discontinuations, and favorable biomarker trends (68.5% showed plasma pTau217 decline; 62.5% showed CSF MTBR-tau243 decline). Unblinded 12-month topline results expected Q1 2027.

INNIO N.V., which completed its IPO on June 5, 2026, reported Q2 2026 equipment order intake of $2.3 billion (+316% YoY), driven by a landmark 1.1 GW data center order and follow-on hyperscaler demand. Equipment order backlog reached $6.6 billion (+279% YoY), providing visibility through 2030. Total revenue was $937.7 million (+42% YoY); Q2 net loss of $16.9 million reflects $81.2 million in one-time IPO costs. Adjusted EBITDA was $172.3 million (+20% YoY). FY2026 guidance: $3.8–3.9 billion revenue and $720–740 million Adjusted EBITDA (+33% at midpoint).

T1 Energy exercised a call option to acquire intellectual property (patents, know-how) related to TOPCon and PERC solar cell technology from Evervolt Green Energy Holding Pte Ltd. Total consideration: $135M ($2M option premium paid upfront + $133M purchase price in four tranches due July 28, 2026 through October 30, 2026). Payment may be satisfied in cash or T1 common stock (at 15% discount to VWAP) or combination thereof, with aggregate stock consideration capped at 19.9% of outstanding shares. T1 previously licensed this IP; ownership eliminates future royalty obligations.

HF Sinclair reported Q2 2026 net income of $892M ($4.93/diluted share), up from $208M ($1.10) in Q2 2025. Adjusted net income was $960M ($5.31/share) vs. $322M ($1.70) YoY. The company returned $265M to shareholders via dividends ($89M) and buybacks ($179M) in Q2, announced a 5% dividend increase from $0.50 to $0.525 per share, and announced plans to separate its Lubricants & Specialties segment into an independent publicly traded company within 12–18 months (targeted H2 2027), while retiring its Mississauga, Ontario base oil refining assets over 2027.

Core Scientific signed a strategic partnership with AMD (announced July 28, 2026) whereby AMD secures more than 500 megawatts of U.S. data center capacity beginning in 2027, with ability to expand up to 2.5 gigawatts. AMD receives market-priced warrants to purchase Core Scientific common stock (specific warrant count and valuation not disclosed). The partnership involves collaboration on infrastructure design and deployment of AMD Instinct GPUs, EPYC CPUs, and ROCm software across Core Scientific's facilities.

Corning reported Q2 2026 core sales of $4.74B (up 17% YoY) and core EPS of $0.78 (up 30% YoY). The company upgraded its Springboard growth plan targeting $20B annualized sales by end-2026, $30B by end-2028, and $40B by end-2030, expecting 19% sales CAGR from Q4 2026 to Q4 2030. Key wins: Amazon announced a multiyear, multibillion-dollar agreement for fiber/connectivity solutions; NVIDIA partnership includes 10x expansion of U.S. optical manufacturing and 50%+ fiber production increase. Optical Communications grew 32% ($2.07B); Solar grew 90% ($438M) with profitability expected to improve in Q3.

Altimmune announced positive topline results from RECLAIM Phase 2 trial of pemvidutide (2.4 mg) in alcohol use disorder (AUD). The trial met its primary endpoint with statistically significant reduction in heavy drinking days versus placebo (p=0.0014; -1.45 days/week difference). Key secondary endpoints also achieved: 64.4% achieved 2-level WHO risk drinking reduction (vs 34.8% placebo, p=0.0049), 42.2% achieved zero heavy drinking days (vs 17.4%, p=0.0066), 9.1% placebo-adjusted weight reduction (p<0.0001). Safety profile generally favorable though nausea (44% vs 24%), constipation (26% vs 6%), and vomiting (18% vs 6%) were elevated; 5 treatment discontinuations due to drug-related AEs (10% vs 0%). Company plans End-of-Phase 2 FDA meeting based on results.

Core Scientific announced a partnership with AMD supporting up to 2.5 GW of leasable capacity, anchored by 15-year agreements for approximately 530 MW across five sites with over $14 billion in potential base contracted revenue. The company increased total leased customer power to 1.1 GW (~$24B contracted revenue) and is billing 437 MW as of mid-July (~$635M annualized colocation revenue). Q2 2026 colocation revenue grew to $136.7M from $77.5M in Q1 2026 and $10.6M in Q2 2025.

Kiniksa reported Q2 2026 ARCALYST net product revenue of $243.6 million (55% YoY growth), prompting a raise of full-year 2026 ARCALYST guidance to $980–995 million from prior guidance of $930–945 million. As of Q2 end, ~21% of 14,000 multiple-recurrence patients were on ARCALYST; KPL-387 Phase 2 data showed rapid pain/inflammation reduction at 300 mg monthly dose, with Phase 3 trial (PASTORALE) now enrolling ~85 patients. Company reported Q2 net income of $25.4 million and maintains $525.9 million cash with no debt.

Edible Garden received a favorable Nasdaq Hearings Panel decision on July 28, 2026, allowing continued listing subject to maintaining a minimum closing bid price of $1.00 per share by August 15, 2026. The company completed a 1-for-45 reverse stock split effective July 13, 2026, and the stock has remained at or above $1.00 since then. Panel jurisdiction continues through November 23, 2026, with no assurance of sustained compliance.

Standard BioTools (market cap $290.9M) received $30,041,683.63 from Illumina on July 24, 2026, as a one-time payment to waive and release all 2026 earnout obligations and future royalty payments (2% on SOMAmer-based NGS kits, 5% on Single SOMAmers) stemming from Illumina's prior acquisition of the SomaLogic business. Simultaneously, Standard BioTools agreed to sell its Mass Cytometry business (CyTOF and Hyperion product lines) to Multiplex Bio for up to $10M (seller's note plus milestone payment), contingent on stockholder approval and closing by end-2026. The $30M payment boosts cash position for pending merger with Treeline Biosciences.

Onfolio Holdings announced it is actively evaluating strategic alternatives to maximize shareholder value, including acquisitions, transformational transactions, and divestitures of underperforming assets. CEO Dominic Wells stated the company has an active acquisition pipeline and intends to pursue immediately accretive M&A while optimizing its portfolio. No specific deals, dollar amounts, timelines, or asset divestiture targets were disclosed.

BiomX amended its $1,250,000 promissory note to Water IO Ltd. (issued April 10, 2026, related to ZorroNet acquisition) by: extending maturity from July 7, 2026 to November 1, 2026; paying $250,000 immediately and $250,000 monthly through November; issuing 800,000 common shares (pending NYSE American clearance and corporate approvals) to satisfy accrued interest and compensate for the extension. Water IO waived the July 7 default retroactively. The share issuance contingency deadline is August 31, 2026.

Bulldog Investors (740,000 Class A shares, ~4.5% of 16.6M Class A outstanding) received $50M breakup fee from terminated Ether Machine deal on April 10, 2026. Bulldog argues directors must distribute ~$2/share ($45M net) to all shareholders before Class A redemption, not retain it for Class B shareholders alone. Directors own Class B shares and face fiduciary duty conflict; Bulldog threatens litigation if board chooses 'self-serving' option by July 24, 2026 deadline.

Brian Malloy, President and CEO of Carpenter Technology, passed away unexpectedly on July 24, 2026. The Board immediately appointed Tony Thene, the Executive Chairman who previously served as CEO from 2015–June 2026, to return to the CEO role effective immediately while remaining Chairman. No financial terms, severance, or transition details were disclosed.

Expand Energy reported Q2 2026 net income of $522M ($2.19/diluted share) with operating cash flow of $1,096M. The company redeemed $1.3B of debt (total debt now $3.7B vs. $5.0B year-end), executed $850M in share repurchases (4% of shares outstanding), and announced an additional $1B buyback authorization. Most significantly, Expand announced the acquisition of Twin Eagle Holdings, creating what management calls North America's leading integrated natural gas company, though financial terms and timing were not disclosed in this release.

Skyworks Solutions and Qorvo announced the executive leadership structure for their pending merger, expected to close in 2026. Phil Brace (Skyworks CEO) will lead the combined company; Qorvo's Bob Bruggeworth joins the board. Nine senior executives from both firms named to report to Brace, including CFO Philip Carter, COO Reza Kasnavi, and heads of key business units (RF, cellular, analog). The merger was previously approved by stockholders on December 23, 2025, and regulatory approvals remain pending.

Skyworks reported Q3 FY2026 revenue of $935 million with non-GAAP diluted EPS of $1.08. The company announced progression toward closing its pending combination with Qorvo Inc., expecting closure within calendar 2026. Key capital allocation changes include replacing the prior repurchase program (expiring Feb 2027) with a new $2 billion stock repurchase authorization, elimination of future quarterly dividends, and anticipated $2 billion in acquisition debt financing for the Qorvo transaction. Q4 guidance: $1,010M–$1,060M revenue with non-GAAP EPS of $1.27 midpoint, incorporating ~$5M incremental net interest expense (~$0.03/share) from partial-quarter Qorvo financing costs.

CoStar reported Q2 2026 revenue of $925M (up 18% YoY from $781M), net income of $55M (vs. $6M prior year), and Adjusted EBITDA of $184M (up 116% YoY from $85M). Residential segment turned Adjusted EBITDA positive for the first time ($12M vs. -$76M prior year). Company reaffirmed full-year 2026 Adjusted EBITDA guidance of $780–$820M and revised revenue guidance to $3.715–$3.755B (growth ~15% YoY).

Bloom Energy reported Q2 2026 revenue of $1,065.4 million (165.5% YoY growth), with product revenue of $935.4 million (215.4% YoY growth). Non-GAAP gross margin expanded 604 basis points to 34.3%. The company raised full-year 2026 revenue guidance to $3.9B–$4.2B (100% YoY growth at midpoint) and non-GAAP operating income guidance to $800M–$900M. Non-GAAP diluted EPS was $0.78 vs. $0.10 in Q2 2025. Operating cash flow was $226.4 million vs. negative $213.1 million in Q2 2025.

Expro Holdings UK 3 Limited agreed to acquire 100% of Enhanced Well Technologies Group AS from seven sellers (Havn Capital 38.2%, Shell Ventures 20.2%, IKM 13.1%, Transocean Sedco Forex 19.5%, and others) for NOK 2,000,000,000 base purchase price plus 5% per annum locked-box interest (prorated from 31 Dec 2025 to closing), less leakage and a NOK 20M holdback. Deal agreement dated 4 May 2026 with Long Stop Date of 30 November 2026. Parent company Expro Group Holdings N.V. provided a parent guarantee.

ASHS entered into a Third Amendment to its credit agreement with Fifth Third Bank dated July 22, 2026. The company acknowledged multiple Designated Events of Default (principally failures to maintain minimum $5M cash and comply with debt ratios), which cannot be cured. Fifth Third agreed to forbear from exercising remedies until June 30, 2027 (subject to earlier termination events), in exchange for a $20,000 extension fee. The company must pursue an Acceptable Sale Transaction with defined milestones and is required to maintain $2M in Qualifying Subordinated Debt proceeds in a blocked account. Outstanding debt: Term Loan $4.69M, Delayed Draw $2.39M, Supplemental $1.94M, Second Supplemental $6.42M.

Chemed reported Q2 2026 consolidated revenue of $673.3M (+8.8% YoY), with diluted EPS of $5.13 (+43.7%) and adjusted diluted EPS of $6.06 (+41.9%). VITAS segment drove growth: net patient revenue $443.3M (+11.9%), ADC 23,687 (+6.1%), admissions 19,125 (+9.0%), and adjusted EBITDA (excl. Medicare Cap) $80.6M (+20.6%). Medicare Cap accrual declined sharply to $500K (Q2 2025: $16.4M). Roto-Rooter revenue grew 3.3% to $229.9M but adjusted EBITDA remained flat at $48.5M. Full-year 2026 adjusted EPS guidance raised from $24.00–$24.75 to $25.00–$25.75 (midpoint +17.8% vs. 2025's $21.55). Share repurchases: 210K shares at $427.81/share in Q2; 1.52M shares (~10.5% reduction) trailing 12 months at avg. $423.63/share.

On July 16, 2026, Sadot entered two financing transactions: (1) Senior Secured Convertible Notes up to $100M principal (initial closing $4M at 8.25% interest, conversion price $17.81/share initially, maturing July 2028, secured by all assets); (2) Equity Purchase Facility Agreement with SZOP for up to $100M in discretionary share sales. This S-1 registers resale of up to 6.0M shares (3.5M conversion shares at floor $2.85, 2.5M advance shares at assumed $20). Company has 1.32M shares outstanding pre-offering; post-offering would reach 7.3M shares. Company faces Nasdaq delisting risk (failed $2.5M stockholders' equity test in May 2026), substantial going-concern doubt, and covenant requiring $750K minimum cash quarterly.

Cadiz Inc. subsidiary Fenner Gap Mutual Water Company signed amended CMAR agreements on July 27, 2026: (1) W.M. Lyles Co. for pump stations (Northern Pipeline Facilities, Project 20-001) with Owner's Approved Budget of $236 million and Phase 2 Construction Price of $218,977,066; (2) Mike Bubalo Construction Co. for pipeline work (Project 20-002) with Owner's Approved Budget of $80 million. Preconstruction phases commenced, construction phase pricing/schedules to be finalized in Phase 2 amendments.

IonQ Inc. received final regulatory approval on July 28, 2026 to complete its acquisition of SkyWater Technology, a U.S.-based semiconductor foundry announced in January 2026. The transaction is expected to close on July 31, 2026. The filing provides no transaction value, share count, or financing details; it states the combination will create a vertically integrated quantum platform with domestic chip manufacturing, with SkyWater continuing as a wholly owned subsidiary.

On July 25, 2026, Westin Ventures Holdings Ltd. (a BVI company) transferred 100% of its issued and outstanding shares to EU Asia Holidays Pte. Ltd. (Singapore) for consideration of US$1.00 and other unspecified valuable consideration. The transfer was completed the same day with share register updated. A joint filing agreement dated July 27, 2026 was executed by Westin Investment Co. Ltd., EU Asia Holidays Pte. Ltd., and Ong Hanjie (director of both entities).

T1 Energy reported Q2 2026 preliminary results of $245–255M in sales (835 MW modules) and a net loss of $34–37M from continuing operations. The company acquired solar IP patents from Evervolt Green Energy for $135M total consideration. G2_Austin Phase 1 capex increased 20% from $425M to $510M, with first production pushed from late 2026 to Q1 2027 due to Texas construction-market cost pressures. T1 also closed the KORE Power acquisition in July 2026 and monetized remaining 2025 Section 45X tax credits for $39.1M.

Repligen reported Q2 2026 revenue of $204M (+12% reported, +13% organic YoY) with adjusted operating income up 55% YoY. The company raised FY26 organic revenue growth guidance to 10.5%–13.5% and adjusted EPS to $2.03–$2.09. Concurrent with earnings, Repligen announced a definitive agreement to acquire BioLife Solutions to strengthen its cell therapy position; the filing provides no acquisition price, payment terms, or deal closing timeline.

SunPower reported Q2 2026 revenue of $56.0M (down $16.8M or 23% from Q1's $72.8M), with non-GAAP operating loss of $12.5M vs. Q1's $12.9M loss. The revenue decline was driven by 1,105 delayed jobs in the Direct Division caused by quality control holds on funding submissions; CEO replaced top management at that division. Operating expenses fell $19.7M (30% drop), including $7.1M in structural fixed-cost reductions. Cash balance dropped to $4.0M (below $10M target) to avoid dilution. Company forecasts Q3 2026 revenue of $75M+ and operating loss under $1M.

Mid Penn Bancorp closed four acquisitions since early 2025: William Penn Bancorporation ($120M, April 2025), Charis Insurance ($4M, May 2025), Cumberland Advisors ($3.2B AUM, January 2026), and 1st Colonial Bancorp ($106M, February 2026). As of June 30, 2026, total assets grew 31% year-over-year to $7.1B (from $5.4B in Q2 2024), gross loans to $5.6B, deposits to $6.0B. Core ROAA improved to 1.26% (from 0.87% in Q2 2024); annualized core EPS of $0.87 on 25.3M weighted average shares. NIM 4.06%, NPAs/Assets 0.52%, TCE/TA 10.5%. Board declared quarterly dividend of $0.23/share (+4.55% from prior quarter), plus $0.05 special dividend in February 2026.

Hubbell Incorporated completed the acquisition of NSI Electrical Buyer, Inc. (NSI Industries), a provider of electrical fittings, connectors, and wire management products, for approximately $3.0 billion in Q2 2026. The company financed this with $900 million in new unsecured term loans, $1.9 billion in senior notes, and commercial paper. Hubbell raised full-year 2026 adjusted diluted EPS guidance to $20.25–$20.55 (from prior guidance) and reported Q2 adjusted diluted EPS of $5.52, up 12% year-over-year, driven by 10% organic sales growth and 15% total sales growth including the acquisition.

Chief Financial Officer ZHANG PINGTING (STFS) bought 2.0M shares (~$2.6M) on the open market (50% of holdings). Open-market insider purchase — historically a bullish signal.

10% owner Market Technology Acquisition Sponsor LLC (MTAK) bought 453K shares (~$4.5M) on the open market (6.2% of holdings). Open-market insider purchase — historically a bullish signal.

Ford reported Q2 2026 revenue of $48.3B (down $1.9B YoY) and a net loss of $1.3B, largely due to a $3.6B non-cash charge related to the previously announced BlueOval SK (BOSK) joint venture disposition. Adjusted EBIT was $2.5B (up $0.4B). The company raised full-year adjusted EBIT guidance to $10.0–$11.0B (from $8.5–$10.5B) and adjusted free cash flow guidance to $6.0–$7.0B (from $5.0–$6.0B), citing strong underlying business performance, industry-leading U.S. quality, pricing power in trucks/hybrids, and growth from Ford Energy.

Varonis reported Q2 2026 SaaS ARR of $726.0 million, up 52% year-over-year (25% excluding conversions). Total revenues reached $180.0 million vs. $152.2 million in Q2 2025; SaaS revenues grew to $171.7 million from $105.9 million. The company raised full-year 2026 guidance: SaaS ARR expected $819.0–$850.0 million (28–33% growth) vs. prior $814.0–$825.0 million; free cash flow guidance raised to $105.0–$110.0 million. GAAP operating loss was ($40.6) million; non-GAAP operating income turned positive at $3.7 million. Cash position: $911.5 million (cash, deposits, securities combined).

Rocky Brands reported Q2 2026 net sales of $118.4M (up 12.0% YoY from $105.6M), with net income of $13.9M or $1.83/diluted share versus $3.6M or $0.48/share in Q2 2025. The earnings surge was primarily driven by recognition of approximately $15.0M in actual and expected IEEPA tariff refunds, which lowered cost of goods sold and boosted gross margin to 51.4% from 41.0% YoY. Gross margin improvement was partially offset by ~$1.1M customer bankruptcy write-off. Total debt decreased 7.6% to $122.4M; inventories down 7.1% to $173.5M. All three segments grew: Wholesale +7.9% to $78.8M, Retail +21.8% to $36.2M, Contract Manufacturing +17.2% to $3.3M.

Slide Insurance reported Q2 2026 gross premiums written of $508.0M (+16.7% YoY), net income of $134.9M (+92.4% YoY), and diluted EPS of $1.06. Combined ratio improved 980 basis points to 57.6%, driven by lower loss ratio (30.2% vs. 37.4%) and operating leverage. The company repurchased 2,998,000 shares at $17.95/share, declared an initial quarterly dividend of $0.07/share (payable Aug 28, 2026), and reiterated FY2026 guidance of $1.85–$1.95B gross premiums and $455–$470M net income.